Related Experiment Video
Updated: Aug 6, 2026
09:04
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
The NLRC4 Inflammasome Drives Myelodysplastic Syndrome by Linking Epigenetic Reprogramming and Innate Immune
Chuan Chen1, Fan Liu2, Tasleem Arif3
1Mayo Clinic, United States.
Blood Advances
|July 24, 2026
Summary
Tet2 deficiency causes chronic inflammation, accelerating myeloid differentiation and triggering myelodysplastic syndromes (MDS) in mice. Targeting the NLRC4 inflammasome pathway may offer new therapeutic strategies for MDS.
Area of Science:
- Hematology
- Immunology
- Molecular Biology
Background:
- Myelodysplastic syndromes (MDS) are linked to chronic inflammation, which can exacerbate disease progression.
- The specific inflammatory and immune signaling pathways involved in MDS hematopoietic stem and progenitor cells (HSPCs) are not fully understood.
Purpose of the Study:
- To investigate the role of Tet2 in regulating inflammatory signaling within HSPCs.
- To elucidate the mechanisms by which inflammation drives MDS pathogenesis in Tet2-deficient models.
Main Methods:
- Utilized Tet2-deficient mice and chimeric mouse models.
- Induced inflammation using lipopolysaccharide (LPS).
- Assessed hematopoietic stem cell (HSC) function, myeloid differentiation, and MDS development.
- Investigated the involvement of the NLRC4 inflammasome pathway, including gene depletion studies.
Main Results:
- Tet2-deficient mice exhibited a hyper-inflammatory state, exacerbated by LPS.
- Chronic inflammation transiently enhanced self-renewal and myeloid differentiation of Tet2-deficient HSPCs but led to HSC exhaustion and MDS development.
- Activation of the NLRC4 inflammasome pathway was identified as a key driver of this phenotype.
- Depletion of Nlrc4 in Tet2-deficient mice significantly impaired MDS development and improved survival.
Conclusions:
- Tet2 deficiency promotes a pro-MDS inflammatory environment through NLRC4 inflammasome activation.
- This study reveals a novel mechanism linking inflammation to MDS pathogenesis.
- The NLRC4 inflammasome represents a potential therapeutic target for managing MDS.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...